Relay Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $10,007 | $-1 |
Gross Profit | -1,368 | 8,612 | -1,376 |
EBITDA | -110,763 | -90,800 | -92,888 |
EBIT | -112,131 | -92,195 | -94,263 |
Net Income | -92,212 | -81,387 | -83,495 |
Net Change In Cash | 0 | 10,007 | -1 |
Free Cash Flow | -65,844 | -52,103 | -89,306 |
Cash | 134,125 | 152,866 | 143,736 |
Basic Shares | 132,821 | 130,843 | 122,576 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $25,546 | $1,381 | $3,029 | $82,654 |
Gross Profit | 20,277 | -2,749 | -896 | 79,105 |
EBITDA | -374,153 | -306,822 | -222,182 | -52,247 |
EBIT | -379,422 | -310,952 | -226,107 | -55,796 |
Net Income | -341,973 | -254,259 | -496,808 | -49,012 |
Net Change In Cash | 25,546 | 1,381 | 3,029 | 82,654 |
Cost of Revenue | -128,325 | -165,827 | 405,692 | |
Free Cash Flow | -304,442 | -238,552 | -77,877 | -104,420 |
Cash | 143,736 | 998,917 | 958,073 | 447,646 |
Basic Shares | 122,576 | 112,233 | 95,136 | 42,619 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.63 |
2024-06-30 | -$0.69 |
2024-03-31 | -$0.62 |
2023-12-31 | -$0.67 |
